How do you pay?

How to pay the least

Ask for the cash price

Yuflyma

Yuflyma is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

What to do

  1. Ask your pharmacy for Yuflyma’s cash price, and one or two other pharmacies too.
  2. Yuflyma’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand name

Yuflyma, the original

Cash priceAsk the pharmacy
Ways to save on Yuflyma

The maker’s card

Celltrion CARES Co-pay Assistance Program

Savings card from Celltrion

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a dose

Sign up on celltrionconnect.com 

Or call 1-877-812-6662.

In the maker’s words

“Under the Program, Eligible Patients may pay as little as $0 for Adalimumab-aaty for each dose.”

From the maker’s offer on celltrionconnect.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

Yuflyma is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldNone sold yet

What it’s used for

What the FDA label says

YUFLYMA is a tumor necrosis factor (TNF) blocker indicated for:

  • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active r heumatoid arthritis.
  • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
  • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active p soriatic arthritis.
  • Reducing signs and symptoms in adult patients with active ankylosing spondylitis.
  • Treatment of moderately to severely active Crohn's disease in adults and pediatric patients 6 years of age and older.
  • Treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.
  • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
  • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older.
  • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.

Source: the FDA label for Yuflyma (CELLTRION USA, Inc.), July 15, 2026. Full label on DailyMed 

Good to know

  • “Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
  • Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.